Today: 3 April 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Ondas Holdings (ONDS) stock jumps on $10 million order news — what investors watch next

Ondas Holdings (ONDS) stock jumps on $10 million order news — what investors watch next

Ondas Holdings shares rose 8.6% to $9.76 Wednesday after announcing $10 million in new autonomous systems orders. Trading volume reached about 156 million shares before the New Year’s Day market holiday. CEO Eric Brock sold 475,000 shares on Dec. 31 for tax reasons, according to a filing. The company expects to issue 2.39 million new shares on Jan. 5, 2026.
1 January 2026
··
Western Digital stock today: WDC slips after year-end drop as New Year’s Day shuts markets

Western Digital stock today: WDC slips after year-end drop as New Year’s Day shuts markets

Western Digital shares fell 2.2% to $172.27 in the final U.S. session of 2025, trailing a broader market decline ahead of the New Year holiday. The NYSE and Nasdaq are closed Thursday, set to reopen Friday. Investors focused on Federal Reserve policy and AI-driven demand for data storage as Western Digital’s outlook remains tied to cloud spending. The company’s next earnings date is unconfirmed, with estimates pointing to early February.
1 January 2026
·
Space Forge sparks plasma on ForgeStar-1 in orbit, pushing semiconductors-in-space closer

Space Forge sparks plasma on ForgeStar-1 in orbit, pushing semiconductors-in-space closer

Space Forge said it generated plasma aboard its ForgeStar-1 satellite, marking the first commercial, free-flying in-space manufacturing of its kind. The test, conducted on Dec. 31, demonstrated that key conditions for semiconductor crystal growth can be achieved and controlled autonomously in orbit. The company aims to produce high-performance semiconductor materials for power electronics and communications.
1 January 2026
···
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Outlook Therapeutics shares dropped from $1.58 to about $0.58 after hours on Dec. 31 after the FDA issued a third complete response letter declining approval for its Lytenava wet-AMD drug. The FDA said more confirmatory efficacy evidence is needed but did not specify requirements. The drug is already approved in the EU and UK. U.S. markets reopen Friday after the New Year’s holiday.
1 January 2026
··
Strategy (MSTR) stock ends 2025 lower as bitcoin slips — what investors watch next

Strategy (MSTR) stock ends 2025 lower as bitcoin slips — what investors watch next

Strategy Inc shares closed down 2.3% at $151.95 as bitcoin slipped to about $87,744 early Thursday, with U.S. stock markets shut for New Year’s Day. The company disclosed it bought 1,229 bitcoins for $108.8 million, bringing total holdings to 672,497 as of Dec. 28. Coinbase fell 2.4%, Marathon Digital dropped 3.6%, and Riot Platforms slipped 0.4% in the last session. MSCI will decide in January on possible benchmark exclusion for Strategy.
1 January 2026
·····
Lidl New Year’s Day opening times 2026: London M25 stores open 10–6 while most UK branches close

Lidl New Year’s Day opening times 2026: London M25 stores open 10–6 while most UK branches close

Lidl will close most UK stores on New Year’s Day except those inside London’s M25, which open 10 a.m. to 6 p.m., according to its holiday schedule. Stores outside the M25, plus in Wales and Scotland, will remain shut Jan. 1 and reopen Jan. 2. Rival Tesco plans to open most larger stores, while Aldi will close. Lidl directs customers to check its app or website for local hours.
1 January 2026
·
DJT stock jumps after Trump Media’s new crypto token plan with Crypto.com; markets closed today

DJT stock jumps after Trump Media’s new crypto token plan with Crypto.com; markets closed today

Trump Media & Technology Group shares rose 5.3% to $13.24 after announcing plans to distribute a new digital token to shareholders in partnership with Crypto.com. The company said each ultimate beneficial owner would receive one token per share, with details to follow. The token is expected to run on the Cronos blockchain in 2026. U.S. markets are closed Thursday for New Year’s Day.
1 January 2026
··
Vodafone Idea share price jumps today after ₹5,836 crore Vodafone Group deal and AGR moratorium headlines

Vodafone Idea share price jumps today after ₹5,836 crore Vodafone Group deal and AGR moratorium headlines

Vodafone Idea shares jumped 6% in Mumbai after the company announced a revised settlement with Vodafone Group promoters, unlocking ₹5,836 crore via cash and shares. Vodafone Group said it would settle the liability with €219 million in cash and 3.28 billion shares. India has granted Vodafone Idea a partial moratorium on $9.76 billion in AGR dues, deferring repayments by a decade, according to a government source.
1 January 2026
··
Sidus Space stock jumps 17% after $16.2 million share sale as market stays shut for New Year’s Day

Sidus Space stock jumps 17% after $16.2 million share sale as market stays shut for New Year’s Day

Sidus Space shares closed up 17% at $3.14 after completing a $16.2 million stock offering, with trading volume near 170 million shares. The stock ranged from $2.48 to $4.20 during the session. CVI Investments and Heights Capital Management disclosed a 7.4% stake in a new filing. Sidus agreed to issue placement agent warrants for up to 540,000 shares at $1.875 each.
1 January 2026
·
1 … 328 329 330 331 332 … 584

Stock Market Today

  • Agenus (AGEN) Shares Poised for Gains on Upward Earnings Estimate Revisions
    April 3, 2026, 2:04 PM EDT. Agenus (AGEN) has seen analysts markedly raise earnings forecasts, signaling growing optimism for the biotech firm. The consensus estimate for the current quarter jumped 289.3% to $1.95 per share, while full-year estimates increased by 151.8% to $1.30 per share. This momentum fueled a 14% stock rise in the past month. Agenus holds a Zacks Rank #1 (Strong Buy), reflecting strong correlations between earnings estimate revisions and stock price moves. Investors may find Agenus a compelling buy as estimates continue improving and stock gains persist.
Go toTop